We are live on ! Find out more
SCM

SKBA Capital Management Portfolio holdings

AUM $728M
1-Year Est. Return 12.18%
This Fund
S&P 500
This Quarter Est. Return
+20.14%
1 Year Est. Return
+12.18%
3 Year Est. Return
+52.29%
5 Year Est. Return
+76.86%
10 Year Est. Return
+235.51%
AUM
$597M
AUM Growth
+$96M
Cap. Flow
+$4.99M
Cap. Flow %
0.84%
Top 10 Hldgs %
28.32%
Holding
80
New
8
Increased
30
Reduced
24
Closed
4

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.19M
2
CB icon
Chubb
CB
+$5.75M
3
CAH icon
Cardinal Health
CAH
+$5.55M
4
CME icon
CME Group
CME
+$5.51M
5
VTRS icon
Viatris
VTRS
+$5.16M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$6.85M
2
KMB icon
Kimberly-Clark
KMB
+$5.32M
3
CVS icon
CVS Health
CVS
+$4.92M
4
ETN icon
Eaton
ETN
+$4.86M
5
INTC icon
Intel
INTC
+$4.83M

Sector Composition

Rank Sector Weight
1 Financials 19.94%
2 Healthcare 16%
3 Industrials 11.27%
4 Consumer Staples 9.47%
5 Energy 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PH icon
51
Parker-Hannifin
PH
$135B
$5.47M 0.92%
20,100
-8,100
-29% -$2.01M
NTRS icon
52
Northern Trust
NTRS
$33.9B
$5.25M 0.88%
56,420
– –
MMM icon
53
3M
MMM
$94.3B
$5.25M 0.88%
35,952
-239
-0.7% -$33.9K
AZN icon
54
AstraZeneca
AZN
$250B
$4.89M 0.82%
48,935
-22,350
-31% -$2.37M
JPM icon
55
JPMorgan Chase
JPM
$950B
$836K 0.14%
6,582
– –
DIS icon
56
Walt Disney
DIS
$181B
$469K 0.08%
2,590
– –
APTV icon
57
Aptiv
APTV
$10.3B
$464K 0.08%
3,560
-350
-9% -$38.9K
PFE icon
58
Pfizer
PFE
$153B
$451K 0.08%
12,250
+5,399
+79% +$198K
GLW icon
59
Corning
GLW
$143B
$439K 0.07%
12,195
-200
-2% -$7.1K
BN icon
60
Brookfield
BN
$108B
$366K 0.06%
16,573
+373
+2% +$7.47K
AL
61
DELISTED
Air Lease Corp
AL
$356K 0.06%
8,010
+200
+3% +$7.17K
TPL icon
62
Texas Pacific Land
TPL
$23.5B
$345K 0.06%
+4,275
New +$271K
PKG icon
63
Packaging Corp of America
PKG
$22.8B
$338K 0.06%
2,450
– –
ETN icon
64
Eaton
ETN
$174B
$330K 0.06%
2,750
-43,000
-94% -$4.86M
BRK.B icon
65
Berkshire Hathaway Class B
BRK.B
$1.13T
$304K 0.05%
1,309
+100
+8% +$22K
REGN icon
66
Regeneron Pharmaceuticals
REGN
$80.8B
$290K 0.05%
600
+10
+2% +$5.4K
FNF icon
67
Fidelity National Financial
FNF
$13.5B
$289K 0.05%
7,696
-208
-3% -$7.02K
ALB icon
68
Albemarle
ALB
$15.5B
$249K 0.04%
+1,690
New +$201K
INTC icon
69
Intel
INTC
$513B
$248K 0.04%
4,970
-98,800
-95% -$4.83M
DISCK
70
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$237K 0.04%
+9,050
New +$198K
BMY icon
71
Bristol-Myers Squibb
BMY
$132B
$230K 0.04%
+3,700
New +$228K
TPH
72
DELISTED
Tri Pointe Homes
TPH
$224K 0.04%
13,000
-200
-2% -$3.54K
BDX icon
73
Becton Dickinson
BDX
$48.2B
$218K 0.04%
+892
New +$208K
RSG icon
74
Republic Services
RSG
$65.7B
$212K 0.04%
2,200
– –
BAC icon
75
Bank of America
BAC
$442B
$204K 0.03%
+6,730
New +$180K
1 2
3
4

Similar funds

SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return

SKBA Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, SKBA Capital Management held 80 positions worth $597M, up 19% from $501M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

SKBA Capital Management's Q4 2020 filing shows 8 new, 30 increased, 24 reduced and 4 closed positions. Its largest new stake was CME Group: 32,400 shares worth $5.9M. The largest sale was Gilead Sciences, an estimated $6.85M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • SKBA Capital Management's largest Q4 2020 buy was CME Group: 32,400 shares worth $5.9M.
  • SKBA Capital Management added most to Merck in Q4 2020, an estimated $9.19M increase.
  • SKBA Capital Management's biggest Q4 2020 reduction was Eaton, cutting an estimated $4.86M.
  • SKBA Capital Management fully exited Gilead Sciences in Q4 2020, selling an estimated $6.85M.
  • SKBA Capital Management's ten largest holdings make up 28% of its $597M portfolio in Q4 2020.
  • SKBA Capital Management opened 8 new positions and closed 4 in Q4 2020.
  • SKBA Capital Management's portfolio value rose 19% quarter-over-quarter to $597M.

Based on SKBA Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.